Detalles de la búsqueda
1.
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail.
Oncologist
; 22(4): 379-385, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28283585
2.
Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.
Expert Rev Pharmacoecon Outcomes Res
; 16(2): 275-84, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26589773
Resultados
1 -
2
de 2
1
Próxima >
>>